Citations

Clear

4207 citation(s) found for "Chen, Yu".

Evaluation of platelet dense granules by transmission electron microscopy in healthy pediatric donors and pediatric patients with suspected platelet disorders
Greenmyer, Jacob R. , Howell, Kyle G., Johnson, Brandi, Drapeau, Noelle, Stromback, Lindsay R., Charlesworth, Jon E. , Gossman, Susan C., Gamez, Jeffrey D., Pruthi, Rajiv K. , Chen, Dong , Fischer, Karen M. , Warad, Deepti

Mayo Clinic

Platelets | November 28, 2025 | Volume: 36 | Issue: 1 | Pages: No page available

10.1080/09537104.2025.2590752 | PMID 41312564 Get It

FLI1 -related thrombocytopenia: piecing together the story
Chen, Dong, Godby, Richard , Chen, Dong

Mayo Clinic

Blood | November 27, 2025 | Volume: 146 | Issue: 22 | Pages: 2728-2728

10.1182/blood.2025030799 | PMID 41307932 Get It

Tissue Microarray-Based Digital Spatial Profiling of Benign Breast Lobules and Breast Cancers: Feasibility, Biological Coherence, and Cross-Platform Benchmarks
Carter, Jodi C., Vierkant, Robert A. , Pacheco-Spann, Laura M. , Vachon, Celine M. , Jensen, Matthew R. , Thompson, E. Aubrey , Kachergus, Jennifer M., Shi, Ji , Radisky, Derek C. , Vierkant, Robert A , Stallings-Mann, Melody, Pacheco-Spann, Laura M , Kachergus, Jennifer, Shi, Ji , Radisky, Derek C , Sherman, Mark E. , Carter, Jodi C., Stallings‐Mann, Melody , Winham, Stacey J. , Vachon, Celine M. , Wang, Chen , Troester, Melissa A. , Degnim, Amy C.

Mayo Clinic

Cancers | November 27, 2025 | Volume: 17 | Issue: 23 | Pages: 3797

10.3390/cancers17233797 | PMID 41374998 Get It

Background: Discovering risk biomarkers in small benign breast disease (BBD) biopsies is constrained by scarce tissue and microanatomic heterogeneity of terminal duct lobular units (TDLUs). We tested whether tissue-sparing tissue microarray (TMA)–based Digital Spatial Profiling (DSP) can deliver reproducible, biologically coherent protein measurements across benign lobules and breast cancers (BCs), and how well DSP aligns with standard immunoassays. Methods: We performed a pilot using tissues from the Mayo Clinic BBD cohort using TMAs representing four contexts: terminal duct lobular units (TDLUs) from BBD biopsies preceding BC and matched BBD-controls, subsequent BCs, and BC-associated TDLUs. We profiled 79 proteins by DSP (37 retained after QC) and benchmarked against chromogenic IHC and OPAL immunofluorescence. Reproducibility was evaluated using intraclass correlation coefficients (ICCs), cross-platform agreement (weighted kappa), marker correlations, and mixed-effects models with false-discovery-rate (FDR) control. Results: We analyzed 368 BBD-TDLU cores (88 cases; 88 controls), 204 BC cores and 110 BC-associated TDLU cores. ICCs were highest in BC tissues, and lower in BC-associated TDLUs and BBD-TDLUs. Agreement was slight–to-fair in TDLUs but moderate (ER/PR) to substantial (BCL2) in BC. DSP recapitulated expected immunologic correlations (CD45 with T-cell, B-cell, and macrophage markers) and tissue-type gradients (BC > BC-associated TDLUs > BBD-TDLUs). Exploratory case–control differences in BBD-TDLUs did not persist after FDR control. Conclusions: TMA-based DSP is feasible in archival breast tissues and yields biologically coherent, cross-platform-benchmarked profiles that are particularly robust in BC, while conserving scarce TDLUS and clarifying current limits of single-marker risk stratification from benign lobules. These data provide a foundation for refined sampling and expanded panels in future TDLU-focused studies.
A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia
Wang, Zhifei , Ellis, Madilyn R. , Ji, Biyun , Sieben, Cynthia J. , Haycraft, Courtney J. , Croyle, Mandy J. , Aghevli, Ariana, Xu, Qingwen , Robichaud, Jielu Hao, Huang, Yan , Yoder, Bradley K. , Hu, Jinghua , Yu, Yong , Ling, Kun , Chen, Chuan , Wang, Zhifei , Gao, Yue, Ellis, Madilyn R , Ji, Biyun , Sieben, Cynthia J , Croyle, Mandy , Xu, Qingwen , Robichaud, Jielu H, He, Kai , Huang, Yan , Yoder, Bradley K , Harris, Peter C , Yu, Yong , Ling, Kun , Chen, Chuan , Gao, Yue , Hao, Jielu , He, Kai , Chen, Chunhua , Harris, Peter C.

Mayo Clinic

Journal of the American Society of Nephrology | November 25, 2025 | Volume: 37 | Issue: 5 | Pages: 944-958

10.1681/asn.0000000942 | PMID 41563398 Get It

Key Points Inositol polyphosphate-5-phosphatase E (INPP5E) and type Ig phosphatidylinositol-4-phosphate 5-kinase (PIPKIγ) coordinated the homeostasis of phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate in primary cilia. Modulating INPP5E or PIPKIγ activity changed the level of polycystin-1 and polycystin-2 in primary cilia. INPP5E inhibition increased the hypomorphic PKD1 variants (PC1-R3277C) in cilia and reduced cystogenesis in the kidney in vitro . Background Autosomal dominant polycystic kidney disease is mainly caused by mutations in PKD1 and PKD2 , which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. PC1 and PC2 assemble a cation channel complex enriched in primary cilium, a sensory organelle associated with various developmental diseases, including polycystic kidney disease (PKD). Accumulating evidence supports the necessity of functional polycystin (PC) complex in cilia to prevent cystogenesis in the kidney, indicating that improving their ciliary levels may ameliorate defects underlying PKD pathogenesis. Yet, molecular mechanisms underlying the ciliary targeting and homeostasis of the PC complex are not fully understood. Methods Indirect immunofluorescence microscopy was used to monitor ciliary levels of PC1 and PC2 in renal epithelial cells. Electrophysiology analysis in oocytes was used to determine the channel activity of the PC complex. Cystogenesis in the kidney was measured using in vitro 3D-Matrigel cell models and ex vivo mouse embryonic kidney models. Results Suppressing inositol polyphosphate-5-phosphatase E (INPP5E) or activating type Ig phosphatidylinositol-4-phosphate 5-kinase raised ciliary levels of the PC complex in both normal renal epithelial cells and cells carrying autosomal dominant polycystic kidney disease mutations that interrupt the trafficking of PCs into cilia, including GANAB inactivation and the trafficking PKD1 mutation p.Arg3277Cys (RC). PC1 RC formed a complex with PC2 and exhibited normal channel activity in vitro . An INPP5E that increases PC1 and PC2 in cilia, suppressed in vitro forskolin-induced cystogenesis of inner medullary collecting duct epithelial cell line 3 cells in 3D Matrigel and ex vivo cyst formation in embryonic Pkd1 RC/RC mouse kidneys. Conclusions Our results demonstrated that increasing the ciliary level of PCs, by manipulating a ciliary phosphoinositide signaling axis, enhanced the functionality of PCs and suppressed cystogenesis of renal epithelial cells in vitro .
Deep Learning for CT Synthesis in Radiotherapy
Guo, Yike, Luo, Yi , Hooshangnejad, Hamed , Zhang, Rui , Feng, Xue , Chen, Quan , Ngwa, Wilfred , Ding, Kai , Chen, Quan , Feng, Xue , Ding, Kai , Guo, Yike

Mayo Clinic

Bioengineering | November 25, 2025 | Volume: 12 | Issue: 12 | Pages: 1297

10.3390/bioengineering12121297 | PMID 41463594 Get It

With the rapid development of artificial intelligence (AI), various deep learning (DL) methods have been introduced into radiation oncology. Among them, the generation of synthetic Computed Tomography (sCT) images has attracted increasing attention, as it supports different clinical scenarios, from image-guided adaptive radiotherapy (IGART) to the simulation-free workflow. This review provides a comprehensive overview of recent studies on DL-based sCT synthesis in radiotherapy from multiple imaging modalities, including Cone-Beam CT (CBCT), Magnetic Resonance Imaging (MRI), and diagnostic CT, and discusses their clinical applications in CBCT-based online adaptive radiotherapy, MRI-guided radiotherapy, and simulation-free workflows. We also examine the architectures of representative DL models such as convolutional neural networks (CNNs) and generative adversarial networks (GANs) and summarize emerging training strategies. Finally, we discuss current challenges of clinical translation of DL algorithms into clinical practice and suggest potential directions for future research. Overall, this paper highlights the potential of AI-driven sCT generation to advance treatment planning by reducing imaging burden, improving dose accuracy, and accelerating workflow efficiency, thus ultimately improving the treatment outcome of patient care.
A Diagnostic Journey through a Rare Hemostatic Disorder
Oviol, Zaraith Sanchez, Sorensen, Eric S, Carmona, P Joy, Zumberg, Marc , Smock, Kristi J. , Moser, Karen , Chen, Dong , Harris, Neil S , Marin, Maximo J , Chen, Dong , Carmona, Pablo

Mayo Clinic

The Journal of Applied Laboratory Medicine | November 25, 2025 | Volume: 11 | Issue: 3 | Pages: 655-660

10.1093/jalm/jfaf195 | PMID 41791891 Get It

Effect of Travel on Sleep Patterns and Athletic Performance in Female Professional Tennis Players: A Retrospective Cohort Study Utilizing WHOOP 3.0 Tracking
Maynard, Jennifer R. , Nadwodny, Jeffrey , Hung, Chen-min S., Punj, Mantavya, Almodovar-Frau, Daniel, Teune, Ben , Stroia, Kathleen , Hung, Chen-Min

Mayo Clinic

Sports Health: A Multidisciplinary Approach | November 22, 2025 | Volume: 18 | Issue: 1 | Pages: 73-82

10.1177/19417381251387717 | PMID 41272436 Get It

Background: Sleep is vital for an athlete’s recovery, physical and mental health, and athletic performance. The impact on circadian rhythm from long-distance travel across multiple time zones has not been studied using wearable technology in female professional tennis players. Hypothesis: Travel between time zones in female professional tennis players leads to circadian desynchronization, causing disruption in sleep patterns, changes in physiologic parameters, and decreased athletic performance. Study Design: Retrospective cohort study. Level of Evidence: Level 3. Methods: A total of 52 female professional tennis players consented to wear, and share the data of, WHOOP 3.0 while traveling and competing on the Women’s Tennis Association (WTA) Tour. Linear mixed models examined the relationship between (1) travel and sleep/recovery and (2) sleep/recovery and match performance. Results: Sleep duration without travel averaged 437 minutes (436.8 ± 2.8). On the first night after travel, for every hour time zone difference (TZD) traveled regardless of direction, players slept 11 minutes less (−11.3 ± 0.96; P < 0.05). Eastward travel further reduced sleep (−24.5 ± 4.2; P < 0.05), while westward travel increased sleep duration (+30.0 ± 4.2; P < 0.05). These effects were reduced on the subsequent 2 nights. Conclusion: Sleep duration reduction was most prominent on the first night after travel, particularly with eastward travel, but improved on subsequent nights. The number of time zones crossed predictably increases the vulnerability for insufficient sleep duration, whereby a 2-hour TZD easterly, and 4-hour TZD westerly, reduces sleep duration <7 hours on the first night. No significant correlation was found between sleep disruption and competition performance in our female professional tennis population. Clinical Relevance: The findings suggest that professional tennis players should, and generally do, arrive at competition locations with enough time to resynchronize their circadian rhythm to the destination time zone; particularly if traveling eastward.
Regulation of Immune Function by CD22 on Antigen-Presenting Cells 3071
Zastrow, Alexi, Crotts, Sydney B. , Maniaci, Brandon Lee, Chen, Yin , Lillemon, Katie, Collett, Chris, Friedman, David J. , Shapiro, Virginia Smith

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.910 Get It

Abstract Description Interactions between ST6GAL1-produced sialic acids and Siglec-2 (CD22) result in immune inactivation. CD22 is a well-characterized regulator of B cell function. We demonstrate that conventional type-2 dendritic cells (cDC2s) and hybrid macrophages express CD22 across the spleen and tumor microenvironment. To understand the function of CD22 on antigen-presenting cells, we generated novel CD22-floxed mice and crossed them with a) Zbtb46-Cre ones (those lacking CD22 on cDC2s and hybrid macrophages) as well as b) CX3CR1-Cre mice (without CD22 on hybrid macrophages nor microglia). From the former cross, we generated subcutaneous flank tumor and colitis-associated colorectal cancer models. CD22 expression on myeloid cells did not impact anti-tumor responses when tumors expressed low CD22 ligand levels. From here, we assess the impact of tumor cell CD22 ligand overexpression on tumor responses. Also, to evaluate CD8 T cell response to CD22, we challenged mice with Theiler’s murine encephalomyelitis virus (TMEV), modeling multiple sclerosis via CD8 T cell hyperactivation. CD22 did not mediate CD8 activation nor infiltration in brains of the latter cross. Thus, CD22 may be functionally redundant across myeloid and B cells. Topic Categories Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
Defining the role of HDAC3 enzymatic vs. adaptor function in T cells 3044
Martinez, Kodi, Shapiro, Michael J. , Chen, Maggie, Choe, Justin, Crotts, Sydney, Maniaci, Brandon, Zastrow, Alexi, Barnes, Jackson, Carlson, Abby, Shapiro, Michael, Lillemon, Katie, Collett, Chris, Shapiro, Virginia Smith

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.884 Get It

Abstract Description Generation of T cells requires dynamic epigenetic alteration of histones to control gene expression at each developmental stage. The Class I deacetylases HDAC1, HDAC2, and HDAC3 have been shown to have 3 functions: adaptor, decrotonylase, and deacetylase activity. The relative importance of each function in T cells is not known. CD2icre HDAC3 cKO mice develop severe colitis and demonstrate that HDAC3 is required during thymocyte development for positive selection, DP survival, and CD4 lineage commitment. Recently, a mutation was identified in HDAC3 that eradicated deacetylase activity (“VRPP”). We generated a novel mouse model with Cre-mediated deletion of endogenous HDAC3 and linked re-expression of HDAC3 VRPP, which maintained adaptor function but lacks both deacetylase and decrotonylase enzymatic activity. Similar to CD2icre HDAC3 cKO mice, HDAC3 VRPP mice have a block in positive selection due to failure to down regulate RORγt and decreased DP cell survival due to increased expression of P2RX7, demonstrating that HDAC3 enzymatic activity is required for these functions. However, when the positive selection defect is bypassed in HDAC3 VRPP mice, CD4+ lineage commitment is restored. Strikingly, this mouse does not develop spontaneous colitis even up to one year of age, although T cell development is still impaired. Thus, there are different roles for HDAC3 enzymatic vs. adaptor function during T cell development which are made evident in HDAC3 VRPP mice. Funding Sources NIAID RO1 AI150100; T32 AI170478; Mayo Clinic Graduate School of Biomedical Sciences Topic Categories Lymphocyte Differentiation and Peripheral Maintenance (LYM)